KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Average Rating of “Moderate Buy” by Brokerages

KORU Medical Systems, Inc. (NASDAQ:KRMD) has received an average recommendation of “Moderate Buy” from the five analysts that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $7.00.

A number of equities analysts have issued reports on the company. Craig Hallum reiterated a “buy” rating and set a $6.00 price target on shares of KORU Medical Systems in a research report on Thursday, August 6th. Weiss Ratings upgraded KORU Medical Systems from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday. Finally, Wall Street Zen downgraded KORU Medical Systems from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th.

Insider Transactions at KORU Medical Systems

In related news, insider Adam Kalbermatten purchased 32,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The stock was bought at an average price of $3.16 per share, with a total value of $101,120.00. Following the acquisition, the insider owned 394,017 shares in the company, valued at $1,245,093.72. The trade was a 8.84% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 18.50% of the company’s stock.

Hedge Funds Weigh In On KORU Medical Systems

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Bard Associates Inc. acquired a new position in shares of KORU Medical Systems during the 2nd quarter worth about $61,000. Arrowstreet Capital Limited Partnership acquired a new stake in KORU Medical Systems in the 1st quarter worth about $79,000. Algert Global LLC boosted its holdings in KORU Medical Systems by 57.2% in the 2nd quarter. Algert Global LLC now owns 22,737 shares of the company’s stock worth $95,000 after buying an additional 8,270 shares during the last quarter. Landscape Capital Management L.L.C. purchased a new stake in KORU Medical Systems during the 2nd quarter worth approximately $124,000. Finally, GSA Capital Partners LLP purchased a new stake in KORU Medical Systems during the 2nd quarter worth approximately $124,000. 58.60% of the stock is owned by hedge funds and other institutional investors.

KORU Medical Systems Trading Down 1.7%

Shares of KORU Medical Systems stock traded down $0.06 during trading hours on Friday, reaching $3.16. The stock had a trading volume of 38,976 shares, compared to its average volume of 176,042. The stock’s 50 day moving average is $3.58 and its 200 day moving average is $3.99. The firm has a market capitalization of $145.33 million, a PE ratio of -79.10 and a beta of 0.43. KORU Medical Systems has a twelve month low of $3.06 and a twelve month high of $6.61.

KORU Medical Systems (NASDAQ:KRMD) last posted its earnings results on Wednesday, August 5th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.03. KORU Medical Systems had a negative return on equity of 10.63% and a negative net margin of 4.03%.The firm had revenue of $12.05 million for the quarter, compared to analysts’ expectations of $11.62 million. As a group, sell-side analysts predict that KORU Medical Systems will post -0.02 earnings per share for the current year.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc (NASDAQ:KRMD) develops, manufactures and sells portable infusion systems for the administration of specialty pharmaceuticals and biologic therapies. Its products are designed to support ambulatory, home-based and other non-hospital infusion settings, giving patients and caregivers alternatives to traditional stationary infusion equipment.

The company’s product portfolio includes the FREEDOM Syringe Infusion System, including the FREEDOM60, FREEDOM35 and FREEDOMEDGE infusion pumps, along with related accessories and administration sets.